Pharmacyclics, Inc. (NASDAQ:PCYC)
| CAPS Rating |
|
|---|
PCYC
VS S&P 500 (SPY)
PCYC News and Commentary
- Will These 3 Health-Care Doubles Keep Running? – The Motley Fool
- Tomorrow's Winners Aren't Where You Think – The Motley Fool
- Drugs To Watch At ASCO 2012 – SeekingAlpha
- ASCO Stocks To Consider This Week – SeekingAlpha
- Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 4 – SeekingAlpha
- Orbimed's $3.4B Filing: 2 Stocks It And Other Healthcare Funds Bought In Q1, And Other Trades – SeekingAlpha
- How High Can Pharmacyclics Fly? – The Motley Fool
- An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABP – 247wallst
- Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CY – 247wallst
How do you think PCYC will perform against the market?
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
97
Outperform
98
Underperform
All-Star Players
20
Outperform
32
Underperform
Wall Street
5
Outperform
1
Underperform
RSS Headlines
Fool UK
